IMRX · Categories · Form 4

IMRX - SEC Form 4 insider transactions

Immuneering Corporation (IMRX) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for IMRX

• 85d
  CHIEF PEOPLE OFFICER Neufeld Leah R was granted 3,628 shares, increasing direct ownership by 14% to 29,598 units (SEC Form 4)

  4 - Immuneering Corp (0001790340) (Issuer)
• 126d
  SEC Form 4 filed by CHIEF LEGAL OFFICER, SECRETARY Bookman Michael

  4 - Immuneering Corp (0001790340) (Issuer)
• 126d
  SEC Form 4 filed by Chief Business Officer Brakewood Harold Eugene

  4 - Immuneering Corp (0001790340) (Issuer)
• 126d
  SEC Form 4 filed by CHIEF SCIENTIFIC OFFICER Hall Brett Matthew

  4 - Immuneering Corp (0001790340) (Issuer)
• 126d
  SEC Form 4 filed by Chief Medical Officer Matushansky Igor

  4 - Immuneering Corp (0001790340) (Issuer)
• 126d
  SEC Form 4 filed by SVP Finance, CAO Morales Mallory

  4 - Immuneering Corp (0001790340) (Issuer)
• 126d
  SEC Form 4 filed by CHIEF PEOPLE OFFICER Neufeld Leah R

  4 - Immuneering Corp (0001790340) (Issuer)
• 126d
  SEC Form 4 filed by PRESIDENT AND CEO Zeskind Benjamin J.

  4 - Immuneering Corp (0001790340) (Issuer)
• 159d
  SEC Form 4 filed by Director Keating Laurie

  4 - Immuneering Corp (0001790340) (Issuer)
• 159d
  SEC Form 4 filed by Director Feinberg Peter

  4 - Immuneering Corp (0001790340) (Issuer)
• 266d
  CHIEF PEOPLE OFFICER Neufeld Leah R was granted 11,815 shares, increasing direct ownership by 110% to 22,544 units (SEC Form 4)

  4 - Immuneering Corp (0001790340) (Issuer)
• 266d
  Chief Accounting Officer Morales Mallory was granted 14,497 shares, increasing direct ownership by 114% to 27,233 units (SEC Form 4)

  4 - Immuneering Corp (0001790340) (Issuer)
• 266d
  CHIEF SCIENTIFIC OFFICER Hall Brett Matthew was granted 14,880 shares, increasing direct ownership by 4% to 374,198 units (SEC Form 4)

  4 - Immuneering Corp (0001790340) (Issuer)
• 360d
  SEC Form 4 filed by Director Hausman Diana

  4 - Immuneering Corp (0001790340) (Issuer)
• 360d
  SEC Form 4 filed by Director Schall Thomas J.

  4 - Immuneering Corp (0001790340) (Issuer)
• 360d
  SEC Form 4 filed by Director Keating Laurie

  4 - Immuneering Corp (0001790340) (Issuer)
• 360d
  SEC Form 4 filed by Director Feinberg Peter

  4 - Immuneering Corp (0001790340) (Issuer)
• 360d
  SEC Form 4 filed by Director Carpenter Robert J

  4 - Immuneering Corp (0001790340) (Issuer)
• 360d
  SEC Form 4 filed by Director Berman Ann E

  4 - Immuneering Corp (0001790340) (Issuer)
• 443d
  SEC Form 4 filed by Chief Medical Officer Matushansky Igor

  4 - Immuneering Corp (0001790340) (Issuer)
• 488d
  SEC Form 4 filed by Chief Accounting Officer Morales Mallory

  4 - Immuneering Corp (0001790340) (Issuer)
• 488d
  SEC Form 4 filed by CHIEF PEOPLE OFFICER Neufeld Leah R

  4 - Immuneering Corp (0001790340) (Issuer)
• 488d
  SEC Form 4 filed by Chief Business Officer Brakewood Harold Eugene

  4 - Immuneering Corp (0001790340) (Issuer)
• 488d
  SEC Form 4 filed by CHIEF SCIENTIFIC OFFICER Hall Brett Matthew

  4 - Immuneering Corp (0001790340) (Issuer)
• 488d
  SEC Form 4 filed by PRESIDENT AND CEO Zeskind Benjamin J.

  4 - Immuneering Corp (0001790340) (Issuer)
• 488d
  SEC Form 4 filed by CHIEF LEGAL OFFICER, SECRETARY Bookman Michael

  4 - Immuneering Corp (0001790340) (Issuer)
• 524d
  SEC Form 4 filed by Director Berman Ann E

  4 - Immuneering Corp (0001790340) (Issuer)
• 524d
  SEC Form 4 filed by Director Feinberg Peter

  4 - Immuneering Corp (0001790340) (Issuer)
• 524d
  SEC Form 4 filed by Director Keating Laurie

  4 - Immuneering Corp (0001790340) (Issuer)
• 631d
  Chief Accounting Officer Morales Mallory was granted 4,458 shares, increasing direct ownership by 54% to 12,736 units (SEC Form 4)

  4 - Immuneering Corp (0001790340) (Issuer)
• 727d
  SEC Form 4 filed by Director Schall Thomas J.

  4 - Immuneering Corp (0001790340) (Issuer)
• 727d
  SEC Form 4 filed by Director Keating Laurie

  4 - Immuneering Corp (0001790340) (Issuer)
• 727d
  SEC Form 4 filed by Director Carpenter Robert J

  4 - Immuneering Corp (0001790340) (Issuer)
• 727d
  SEC Form 4 filed by Director Feinberg Peter

  4 - Immuneering Corp (0001790340) (Issuer)
• 727d
  SEC Form 4 filed by Director Berman Ann E

  4 - Immuneering Corp (0001790340) (Issuer)
• 727d
  SEC Form 4 filed by Director Hausman Diana

  4 - Immuneering Corp (0001790340) (Issuer)
• 748d
  SEC Form 4 filed by Bookman Michael

  4 - Immuneering Corp (0001790340) (Issuer)
• 748d
  SEC Form 4 filed by Morales Mallory

  4 - Immuneering Corp (0001790340) (Issuer)
• 748d
  SEC Form 4 filed by Brakewood Harold Eugene

  4 - Immuneering Corp (0001790340) (Issuer)
• 748d
  SEC Form 4 filed by Neufeld Leah R

  4 - Immuneering Corp (0001790340) (Issuer)
• 798d
  Cormorant Asset Management, Lp sold $1,160,181 worth of shares (400,000 units at $2.90) (SEC Form 4)

  4 - Immuneering Corp (0001790340) (Issuer)
• 813d
  Bookman Michael was granted 1,448 shares, increasing direct ownership by 60% to 3,850 units (SEC Form 4)

  4 - Immuneering Corp (0001790340) (Issuer)
• 814d
  Cormorant Asset Management, Lp sold $2,749,003 worth of shares (909,091 units at $3.02) (SEC Form 4)

  4 - Immuneering Corp (0001790340) (Issuer)
• 820d
  SEC Form 4 filed by Schall Thomas J.

  4 - Immuneering Corp (0001790340) (Issuer)
• 852d
  SEC Form 4 filed by Morales Mallory

  4 - Immuneering Corp (0001790340) (Issuer)
• 852d
  SEC Form 4 filed by Neufeld Leah R

  4 - Immuneering Corp (0001790340) (Issuer)
• 852d
  SEC Form 4 filed by Brakewood Harold Eugene

  4 - Immuneering Corp (0001790340) (Issuer)
• 852d
  SEC Form 4 filed by Bookman Michael

  4 - Immuneering Corp (0001790340) (Issuer)
• 852d
  SEC Form 4 filed by Hall Brett Matthew

  4 - Immuneering Corp (0001790340) (Issuer)
• 852d
  SEC Form 4 filed by Zeskind Benjamin J.

  4 - Immuneering Corp (0001790340) (Issuer)
• 890d
  SEC Form 4 filed by Keating Laurie

  4 - Immuneering Corp (0001790340) (Issuer)
• 890d
  SEC Form 4 filed by Feinberg Peter

  4 - Immuneering Corp (0001790340) (Issuer)
• 1091d
  SEC Form 4 filed by Keating Laurie

  4 - Immuneering Corp (0001790340) (Issuer)
• 1091d
  SEC Form 4 filed by Hausman Diana

  4 - Immuneering Corp (0001790340) (Issuer)
• 1091d
  SEC Form 4 filed by Feinberg Peter

  4 - Immuneering Corp (0001790340) (Issuer)
• 1091d
  SEC Form 4 filed by Carpenter Robert J

  4 - Immuneering Corp (0001790340) (Issuer)
• 1091d
  SEC Form 4 filed by Berman Ann E

  4 - Immuneering Corp (0001790340) (Issuer)
• 1092d
  SEC Form 4 filed by Morales Mallory

  4 - Immuneering Corp (0001790340) (Issuer)
• 1164d
  SEC Form 4 filed by Brakewood Harold Eugene

  4 - Immuneering Corp (0001790340) (Issuer)
• 1209d
  SEC Form 4 filed by Morales Mallory

  4 - Immuneering Corp (0001790340) (Issuer)

Other IMRX categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends